Evidence map›Paper›PMID 39883370›Full record

ArticleAIDS and behavior2025

Experiences of Disclosure, Resilience and Viral Suppression among People Living with HIV in Ghana.

Mary Anne Elizabeth Roach, Talia Loeb, Amrita Rao, Carrie Lyons, Gnilane Turpin, Omar Syarif, Pim Looze, Katarzyna Lalak, Jean Anoubissi, Sophie Brion and 7 more

Abstract read
In one paragraph

Article in AIDS and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Mary Anne Elizabeth RoachDepartment of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD, 21205, USA. mroach7@jh.edu.ORCID http://orcid.org/0009-0007-2064-3248
Talia LoebDepartment of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD, 21205, USA.
Amrita RaoDepartment of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD, 21205, USA.
Carrie LyonsDepartment of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD, 21205, USA.
Gnilane TurpinGlobal Network of People Living with HIV (GNP+), Amsterdam, Netherlands.
Omar SyarifGlobal Network of People Living with HIV (GNP+), Amsterdam, Netherlands.
Pim LoozeGlobal Network of People Living with HIV (GNP+), Amsterdam, Netherlands.
Katarzyna LalakGlobal Network of People Living with HIV (GNP+), Amsterdam, Netherlands.
Jean AnoubissiGlobal Network of People Living with HIV (GNP+), Amsterdam, Netherlands.
Sophie BrionThe International Committee of Women Living with HIV (ICW), London, UK.
Keren DunawayThe International Committee of Women Living with HIV (ICW), London, UK.
Laurel SpragueUNAIDS, Geneva, Switzerland.
Carlos Garcia de Leon MorenoUNAIDS, Geneva, Switzerland.
Daria MatyushinaUNAIDS, Geneva, Switzerland.
Elsie AyehGlobal Network of People Living with HIV (GNP+), Amsterdam, Netherlands.
Stefan BaralDepartment of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD, 21205, USA.
Katherine RucinskiDepartment of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Anna Palmer Durbin · 2012 to 2026
$67.0M
Johns Hopkins HIV Epidemiology and Prevention Sciences Training ProgramT32AI102623 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Shruti H Mehta · 2013 to 2026
$5.3M
Statistical Models for Estimating and Projecting HIV/AIDS EpidemicsR01AI136664 · NIAID · PENNSYLVANIA STATE UNIVERSITY, THE · PI BAO, LE · 2017 to 2021
$3.6M
Leveraging Big Data Science to Focus the HIV Response in Countries with Generalized HIV EpidemicsR01AI170249 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BARAL, STEFAN DAVID · 2022 to 2025
$2.9M
The Johns Hopkins and Emory University AIDS Research Center – Center for HIV and Mental Health Stigma Elimination Strategies (CHIMES) P30MH136919 · NIMH · JOHNS HOPKINS UNIVERSITY · PI Tiara C. Willie · 2024 to 2026
$2.9M
Implementation Research to Optimize ART Delivery for Adolescents and Young Adults Living with HIVK01MH129226 · NIMH · JOHNS HOPKINS UNIVERSITY · PI Katherine B Rucinski · 2022 to 2026
$792k
Program and implementation context of a housing support initiative to address homelessness and improve HIV service uptake among youth in the United StatesK01MD020002 · NIMHD · JOHNS HOPKINS UNIVERSITY · PI Amrita Rao · 2024 to 2026
$381k
National Institute of Health 1P30AI094189NIAID NIH HHS P30 AI094189NIAID NIH HHS R01 AI136664NIAID NIH HHS R01 AI170249NIAID NIH HHS T32 AI102623NIMHD NIH HHS K01 MD020002NIMH NIH HHS K01 MH129226NIMH NIH HHS K01MH129226NIMH NIH HHS P30 MH136919NIMH NIH HHS P30MH136919U.S. National Institute of Allergy and Infectious Diseases R01AI136664U.S. National Institute of Allergy and Infectious Diseases R01AI170249
6 · The paper itself

Abstract

Support for people living with HIV (PLHIV) as they disclose their HIV status can impact continuity of HIV treatment and adherence to antiretrovirals. In the presence of multi-level adversities, resilience among PLHIV can promote health-seeking behaviors and better health outcomes. However, few studies have examined how disclosure experience and resilience work together to impact HIV treatment outcomes among PLHIV. In this study, we assessed the relationships between HIV disclosure experience, resilience and viral suppression among PLHIV in Ghana. The Stigma Index 2.0 questionnaire was completed by 1827 PLHIV in Ghana in 2021 to assess demographics, experiences of HIV related stigma, resilience-factors, and other self-reported outcomes including viral suppression. Participants were also asked to classify their disclosure experience with friends and family as positive or negative. Multivariable log-binomial models estimated adjusted prevalence ratios (PR) and 95% confidence intervals (CI) for the association between disclosure experience and viral suppression. A dichotomized measure of resilience was evaluated as a potential effect measure modifier, and subgroup analyses explored associations by key population. Overall, those with a positive disclosure experience were more likely to have achieved viral suppression than participants with a negative disclosure experience (PR 1.09, 95%CI:1.00-1.19). This association increased among participants with lower resilience scores (PR 1.33, 95%CI:1.11-1.60). Findings suggest the importance of early positive social interactions for sustained engagement in ART, particularly for marginalized populations who face psychosocial and structural stigmas that challenge resilience. Ultimately, optimizing HIV treatment necessitates interventions that mitigate community stigma and promote resilience-building strategies for PLHIV in Ghana.

Indexed as

HIV InfectionsResilience, PsychologicalSocial StigmaViral LoadAdultAnti-HIV AgentsCross-Sectional StudiesFemaleGhanaHumansMaleMiddle AgedSurveys and QuestionnairesYoung AdultAnti-HIV AgentsGhanaHIV stigmaHIV treatmentKey populationsResilience

Identifiers

PMID39883370
PMCPMC12074885

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.